HLLY entered the week still digesting a brutal post-earnings session — and the aftershocks kept coming.
Q1 results, reported on May 6, sent the stock down 23% in a single day, landing at a price where it is now trading near multi-year lows around $2.82. The full week shows a net decline of 9%. Friday offered a partial reprieve — shares bounced 11.5% — but the damage from the earnings release still defines the setup.
The earnings print was the headline. Holley reported into a difficult environment: Q1 revenue fell roughly 3.7% year-over-year, with management attributing soft demand to poor weather in early 2026 and ongoing inventory adjustments across the channel. The company is guiding for back-half weighted growth, banking on new product launches and expanded digital and third-party marketplace distribution. The debt load remains the structural concern: net debt runs above $550 million against quarterly EBITDA around $24 million, leaving the debt/EBITDA ratio near 5.2x. That limits financial flexibility and amplifies any revenue miss.
Both covering analysts trimmed targets in the two days following the print. Canaccord Genuity maintained its Buy but cut its target from $8 to $7. Benchmark held its Buy while lowering to $4, citing the inventory and weather headwinds the company flagged. The consensus mean target now sits near $4.67 — more than 65% above Friday's close — but the spread between targets tells a different story: one firm sees the stock at $4, another at $7, and Telsey Advisory has an Outperform with a $5 target. That's a wide range. The bulls are leaning on operational self-help, margin recovery and new product momentum. The bear case is more prosaic: back-half growth stories can struggle to close the gap when balance sheet stress limits investment flexibility and consumer discretionary spending on performance auto parts remains uneven.
Positioning in the lending market is essentially a non-story. Short interest is just 1.5% of the free float — a level too low to generate meaningful squeeze dynamics. Availability is well into normal territory and borrowing costs remain near the floor at 0.65% annualised, ticking up about 25% over the week but from a trivial base. The ORTEX short score of 31.7 is unremarkable, consistent with a stock where shorts are present but not pressing. Options sentiment has eased since mid-April, when the PCR was running above 1.8. It has now dropped to 0.75, modestly below the 20-day mean of 0.98 — call activity has picked up relative to puts, consistent with some positioning for a recovery bounce. The PCR z-score of -0.48 keeps this within normal range, so there's no strong directional signal from options either way.
Institutional ownership shows a concentrated structure. Sentinel Capital holds over 20% of shares outstanding with no recent change. MidOcean (8.5%) is essentially flat. The more active recent moves are at the margin: BlackRock added over a million shares through April, Vanguard added around 587,000, and Dimensional built a small position. These are passive and systematic flows, not a directional call. Insider activity through the most recent filing window — March 2026 — shows the CFO and an EVP both sold shares in the $2.72-$3.46 range, small amounts but at prices above current levels. The CEO sold $755,000 worth in December 2025 near $4.24. The net 90-day insider position was modestly positive on shares, driven by award vesting offset by open-market sales, but there is no meaningful fresh buying signal from management.
Valuation after the selldown is more interesting. EV/EBITDA now sits near 6.1x on the snapshot data, and the earnings yield has improved to about 14.4%. On a price-to-book basis the stock trades near 0.66x, though the negative tangible book value (given goodwill from past acquisitions) complicates any simple asset-value argument. The key question for the remainder of 2026 is whether the back-half recovery the company is guiding for — new product launches, weather normalisation, digital channel gains — actually materialises in revenue, and whether that translates into free cash flow improvement sufficient to address the debt burden. Friday's bounce suggests there are buyers at these levels, but with no next earnings date yet confirmed, the catalyst calendar is blank for now.
See the live data behind this article on ORTEX.
Open HLLY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
